Is bilateral calf and posterior thigh cramping after starting Yaz (drospirenone/ethinyl estradiol) a sign of deep‑vein thrombosis and how should it be evaluated and managed?

Bilateral Calf and Posterior Thigh Cramping After Starting Yaz: Evaluation and Management

Stop Yaz immediately and obtain urgent bilateral lower extremity duplex ultrasound to rule out deep vein thrombosis (DVT), as drospirenone-containing oral contraceptives carry an elevated thrombotic risk and leg cramping can be an early manifestation of venous thromboembolism. 1, 2

Why This Matters

Yaz (drospirenone/ethinyl estradiol) is contraindicated in patients with deep vein thrombosis or pulmonary embolism and carries a known increased risk of venous thromboembolism (VTE) compared to other oral contraceptives 1. Multiple studies demonstrate that drospirenone-containing contraceptives have a 1.5 to 3.3-fold increased VTE risk compared to levonorgestrel-containing pills, with incidence rates ranging from 23.0 to 136.7 per 100,000 woman-years 2, 3, 4. The bilateral nature of symptoms and involvement of both calf and posterior thigh regions raises particular concern for thrombotic disease.

Immediate Clinical Actions

Discontinue Yaz Now

• Do not wait for imaging results to stop the medication 1
• The FDA label explicitly lists high risk of arterial or venous thrombotic diseases as a contraindication 1
• VTE risk is highest in the first year of use, making new users particularly vulnerable 5

Obtain Complete Duplex Ultrasound

• Order complete bilateral lower extremity venous duplex ultrasound from inguinal ligament through calf veins 6
• Do NOT accept limited protocols that skip the calf veins—5% of DVTs are isolated to the calf, and 9-21% of calf DVTs propagate proximally 6
• Complete protocols have 97.8% specificity for calf DVT 6

Key Clinical Pitfalls to Avoid

Don't Dismiss Calf Symptoms

• Isolated calf DVT is not benign—32% propagate, with 46% of those extending into popliteal or larger veins 7
• Bilateral symptoms do not rule out DVT; they may indicate bilateral thrombosis or other serious pathology
• Cramping can be an atypical presentation of DVT rather than classic unilateral swelling and pain

Don't Use Limited Ultrasound Protocols

• Limited protocols that skip calf veins will miss isolated calf DVT 6
• If calf DVT is found and not anticoagulated, mandatory serial ultrasounds at 1 week and 2 weeks are required to monitor for proximal propagation 6
• Patient compliance with follow-up imaging is inconsistent, and missed follow-up can have severe consequences 6

If DVT is Confirmed

Anticoagulation

• Initiate therapeutic anticoagulation immediately 6
• Permanent discontinuation of Yaz and all estrogen-containing contraceptives 1
• Serial ultrasound is not needed if anticoagulation is started, unless clinical condition changes 6

If DVT is Not Confirmed

Even with negative imaging, consider:

• Alternative contraception immediately—do not restart Yaz 1
• Progestin-only methods carry no increased VTE risk and are safer alternatives 8, 9
• The drospirenone component specifically appears to drive the elevated thrombotic risk when combined with ethinyl estradiol 4, 10

Risk Context for Drospirenone

The evidence consistently shows drospirenone formulations carry higher VTE risk:

• 4.0 to 6.3-fold increased risk versus non-users of oral contraceptives 2
• Higher risk than levonorgestrel-containing pills across multiple large studies 2, 3, 4
• One autopsy case documented fatal pulmonary thromboembolism in a young woman taking Yaz for 17 months, with drospirenone detected postmortem 5
• The 20 mcg ethinyl estradiol formulation (Yaz) may carry equal or higher risk than the 30 mcg formulation, contrary to expectations 3, 5

Recommended Alternative Contraception

If contraception is still desired:

• Progestin-only pills (norethindrone or desogestrel)—no VTE risk 8, 9
• Levonorgestrel IUD—no systemic VTE risk 6
• Avoid all ethinyl estradiol-containing combined hormonal contraceptives 8, 9